Categories AlphaGraphs, Earnings, Finance

Infographic: A snapshot of Visa’s Q2 2025 earnings report

Credit card company Visa, Inc. (NYSE: V) has reported an increase in second-quarter adjusted profit, reflecting a 9% growth in revenues.

Visa Q2 2025 earnings infographic

Net income, on a reported basis, was $4.6 billion or $2.32 per share in the second quarter, compared to $4.7 billion or $2.29 per share in the same period of fiscal 2024. On an adjusted basis, earnings per share increased 10% annually to $2.76 per share in the March quarter.

The growth was driven by a 9% increase in second-quarter revenues to $9.6 billion. Revenue grew across all of the company’s four operating segments.

“Visa’s strong 9% fiscal second-quarter net revenue growth was driven by healthy trends in payments volume, cross-border volume, and processed transactions,” said Ryan McInerney, Chief Executive Officer, Visa.

Prior performance

  • Visa Q4 2024 earnings infographic
  • Visa Q3 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Infographic: How Lennar (LEN) performed in Q4 2025

Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the fourth quarter of 2025, compared to $9.9 billion reported in the same period a year ago. Net earnings

Paychex expected to report higher revenue and earnings for Q2 FY26

Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the

Signet Jewelers (SIG): A look at the progress made on Grow Brand Love

Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top